Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|September 25, 2023
Proteotoxic stresses stimulate dissociation of UBL4A from the tail-anchored protein recognition complexTakumi Hagiwara, Ryosuke Minami, Chizuru Ushio, et al.
Biology Open|February 17, 2018
ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrestAya Noguchi, Shungo Adachi, Naoto Yokota, et al.
Biochemical and Biophysical Research Communications|May 1, 2018
Novel phosphorelay-dependent control of ZFP36L1 protein during the cell cycleMakoto Kondo, Aya Noguchi, Yuki Matsuura, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|May 6, 2014
Reduced scytonemin isolated from Nostoc commune suppresses LPS/IFNγ-induced NO production in murine macrophage RAW264 cells by inducing hemeoxygenase-1 expression via the Nrf2/ARE pathwayTomohiro Itoh, Mamoru Koketsu, Naoto Yokota, et al.
Journal of the American Society of Hypertension : JASH|October 30, 2012
Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesityJohji Kato, Naoto Yokota, Noboru Tamaki, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 3, 2010
Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertensionJohji Kato, Naoto Yokota, Noboru Tamaki, et al.
Biochemical and Biophysical Research Communications|August 12, 2014
Evidence for participation of GCS1 in fertilization of the starlet sea anemone Nematostella vectensis: implication of a common mechanism of sperm-egg fusion in plants and animalsEerdundagula Ebchuqin, Naoto Yokota, Lixy Yamada, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 27, 2012
Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension under clinical setting (PALM-1 Extension Study)Toshihiro Kita, Naoto Yokota, Yoshinari Ichiki, et al.
Pageof 4